522 studies found for:    Spasticity
Show Display Options
Rank Status Study
21 Completed
Has Results
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Other: Placebo
22 Recruiting Comparison of Electrophysiologic and Ultrasound Guidance for Onabotulinum Toxin A Injections in Focal Upper Extremity Dystonia and Spasticity
Conditions: Dystonia;   Focal Dystonia;   Musician's Dystonia;   Muscle Spasticity
Interventions: Procedure: BoNT injection;   Procedure: US guidance;   Procedure: E-stim Guidance
23 Completed
Has Results
Safety and Efficacy of Oral Fampridine-Sustained Release (SR) for the Treatment of Spasticity Resulting From Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Interventions: Drug: Fampridine-SR;   Drug: Placebo
24 Completed The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Procedure: Penile Vibratory Stimulation
25 Withdrawn Spasticity Registry Evaluating Epidemiology, Treatment Patterns and Clinical Needs
Condition: Muscle Spasticity
Intervention: Other: No Intervention
26 Recruiting Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
Conditions: Cerebral Palsy;   Spasticity
Interventions: Drug: IncobotulinumtoxinA (8 Units per kg body weight);   Drug: IncobotulinumtoxinA (6 Units per kg body weight);   Drug: IncobotulinumtoxinA (2 Units per kg body weight)
27 Completed Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: arbaclofen;   Drug: baclofen;   Drug: Placebo
28 Recruiting Study of the Effects on Motor Recovery of Early Post-stroke Spasticity Treatment
Condition: Muscle Spasticity
Interventions: Drug: botulinum A toxin;   Drug: Baclofen;   Drug: Placebo toxin;   Drug: placebo baclofen
29 Unknown  A Prospective Study of Spasticity in Individuals With Multiple Sclerosis
Condition: Spasticity
Intervention:
30 Active, not recruiting Shockwaves Therapy and Botulinum Toxin for the Treatment of Spasticity in Patients With Cerebral Palsy. A Cross Over RCT
Conditions: Spasticity;   Cerebral Palsy
Interventions: Device: shock waves;   Drug: Botulinum Toxin Type A
31 Terminated Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
32 Completed
Has Results
Evaluate the Maintenance of Effect After Long-term Treatment With Sativex® in Subjects With Symptoms of Spasticity Due to Multiple Sclerosis
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
33 Recruiting Compare Two Guidance Techniques for Botulinum Toxin Injections for the Treatment of Limb Spasticity and Focal Dystonia
Conditions: Spasticity;   Focal Dystonia;   Tremor, Limb
Interventions: Device: E-stim;   Device: Ultrasound
34 Completed One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: arbaclofen
35 Completed DTI Study of the Influence of Physiotherapy on Distribution of BoNT in Spastic Muscle
Condition: Spasticity
Intervention: Other: physiotherapy
36 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Condition: Muscle Spasticity
Interventions: Drug: tolperisone HCl (AV650);   Drug: Placebo
37 Active, not recruiting Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients
Conditions: Muscle Spasticity;   Multiple Sclerosis
Interventions: Biological: incabotulinumtoxinA;   Biological: Placebo
38 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
39 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:
40 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years